نمایش پرونده ساده آیتم

dc.contributor.authorLafzi, A
dc.contributor.authorFarahani, RMZ
dc.contributor.authorShoja, MAM
dc.date.accessioned2018-08-26T09:31:54Z
dc.date.available2018-08-26T09:31:54Z
dc.date.issued2007
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/57205
dc.description.abstractAim: The aim of this article is to present a case of a phenobarbital- induced gingival hyperplasia (GH), discuss possible etiological mechanisms of drug-induced GH, and to present a concise review of the literature. Background: GH is a well-known complication associated with anticonvulsant phenytoin, antihypertensive calcium channel blockers, and immunosuppressant cyclosporine therapy. Sodium valproate and primidone has very rarely been found to cause GH. Report: An extremely rare case of phenobarbital-induced GH in a 28-year-old male patient who had received this drug for three years is presented. The histological examination of the lesion revealed a hyperplastic epithelium, epithelial acanthosis, and elongated rete ridges as well as obviously enhanced dense collagenous fibers and proliferation of fibroblasts. Summary: Phenobarbital-induced GH is a rare clinical entity which necessitates meticulous evaluation. However, it seems to show a benign behavior with reference to recurrence after surgical excision.
dc.language.isoEnglish
dc.relation.ispartofJournal of Contemporary Dental Practice
dc.titlePhenobarbital-induced gingival hyperplasia
dc.typeArticle
dc.citation.volume8
dc.citation.issue6
dc.citation.spage50
dc.citation.epage56
dc.citation.indexScopus


فایلهای درون آیتم

Thumbnail

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم